Veru, Inc. (VERU)
2.43
-0.03 (1.22%)
Upcoming Events
Latest Headlines
Westlake Securities Starts Veru, Inc. (VERU) at Buy
October 6, 2026 1:59 PM - StreetInsider
Form 4 VERU INC. For: Aug 13 Filed by: BARNETTE K GARY
August 17, 2026 4:26 PM - SEC Filing
Form 10-Q VERU INC. For: Jun 30
August 10, 2026 8:52 AM - SEC Filing
Veru, Inc. (VERU) Tops Q3 EPS by 1c
August 10, 2026 8:13 AM - StreetInsider
Form 8-K VERU INC. For: Aug 10
August 10, 2026 7:00 AM - SEC Filing
Veru posts Q3 loss, reports full enrollment in obesity drug trial
August 10, 2026 6:30 AM - StreetInsider
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
August 10, 2026 6:30 AM - Globe NewsWire
Veru receives patent allowance for enobosarm and semaglutide combo
August 4, 2026 8:30 AM - StreetInsider
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
August 4, 2026 8:30 AM - Globe NewsWire
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
August 3, 2026 8:30 AM - Globe NewsWire
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
July 30, 2026 8:30 AM - Globe NewsWire
Veru completes enrollment in Phase 2b obesity combination drug trial
July 27, 2026 8:10 AM - StreetInsider
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
July 27, 2026 8:10 AM - Globe NewsWire
Full Article List
